Skip to main content
Log in

Anti-angiogenic effect of triterpenoidal saponins from Polygala senega

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Senegasaponins [senegin II (1), senegin III (2), senegin IV (3), senegasaponin a (4), and senegasaponin b (5)] from Polygala senega were re-discovered as selective anti-proliferative substances against human umbilical vein endothelial cells (HUVECs). Senegasaponins (15) showed anti-proliferative activity against HUVECs with IC50 values in the range 0.6–6.2 μM, and the selective index was 7–100-fold in comparison with those for several cancer cell lines, while the desacyl mixture of senegasaponins (6) and tenuifolin (7) lost anti-proliferative activity, indicating that the 28-O-glycoside moiety and methoxycinnamoyl group were essential for the HUVEC-selective growth inhibition of senegasaponins. Senegin III (2) inhibited the vascular endothelial growth factor (VEGF)-induced in vitro tubular formation of HUVECs and basic fibroblast growth factor (bFGF)-induced in vivo neovascularization in the mouse Matrigel plug assay. Moreover, senegin III (2) suppressed tumor growth in the ddY mice s.c.-inoculated murine sarcoma S180 cells. The analysis of the action mechanism of senegin III (2) suggested that the induction of pigment epithelium-derived factor (PEDF) would contribute to the anti-angiogenic effects of senegasaponins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31

    Article  CAS  PubMed  Google Scholar 

  2. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6

    Article  CAS  PubMed  Google Scholar 

  3. Fan TP, Jaggar R, Bicknell R (1995) Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16:57–66

    Article  CAS  PubMed  Google Scholar 

  4. Aoki S, Cho SH, Ono M, Kuwano T, Nakao S, Kuwano M, Nakagawa S, Gao JQ, Mayumi T, Shibuya M, Kobayashi M (2006) Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells. Anticancer Drugs 17:269–278

    Article  CAS  PubMed  Google Scholar 

  5. Aoki S, Sanagawa M, Watanabe Y, Setiawan A, Arai M, Kobayashi M (2007) Novel isomarabarican triterpenes, exhibiting selective anti-proliferative activity against vascular endothelial cells, from marine sponge Rhabdastrella globostellata. Bioorg Med Chem 15:4818–4828

    Article  CAS  PubMed  Google Scholar 

  6. Aoki S, Watanabe Y, Sanagawa M, Setiawan A, Kotoku N, Kobayashi M (2006) Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex. J Am Chem Soc 128:3148–3149

    Article  CAS  PubMed  Google Scholar 

  7. Yoshikawa M, Murakami T, Ueno T, Kadoya M, Matsuda H, Yamahara J, Murakami N (1995) E-senegasaponins A and B, Z-senegasaponins A and B, Z-senegins II and III, new type inhibitors of ethanol absorption in rats from senegae radix, the roots of Polygala senega L. var latifolia Torrey et Gray. Chem Pharm Bull 43:350–352

    CAS  PubMed  Google Scholar 

  8. Yoshikawa M, Murakami T, Ueno T, Kadoya M, Matsuda H, Yamahara J, Murakami N (1995) Bioactive saponins and glycosides. I. Senegae radix. (1): E-senegasaponins a and b and Z-senegasaponins a and b, their inhibitory effect on alcohol absorption and hypoglycemic activity. Chem Pharm Bull 43:2115–2122

    CAS  PubMed  Google Scholar 

  9. Yoshikawa M, Murakami T, Matsuda H, Ueno T, Kadoya M, Yamahara J, Murakami N (1996) Bioactive saponins and glycosides. II. Senegae Radix. (2): Chemical structures, hypoglycemic activity, and ethanol absorption-inhibitory effect of E-senegasaponin c, Z-senegasaponin c, and Z-senegins II, III, and IV. Chem Pharm Bull 44:1305–1313

    CAS  PubMed  Google Scholar 

  10. Estrada A, Katselis GS, Laarveld B, Barl B (2000) Isolation and evaluation of immunological adjuvant activities of saponins from Polygala senega L. Comp Immunol Microbiol Infect Dis 23:27–43

    Article  CAS  PubMed  Google Scholar 

  11. Sakuma S, Shoji J (1981) Studies on the constituents of the root of Polygala tenuifolia Willdenow. II. On the structures of onjisaponins A, B and E. Chem Pharm Bull 30:810–821

    Google Scholar 

  12. Desbène S, Hanquet B, Shoyama Y, Wagner H, Lacaille-Dubois MA (1999) Biologically active triterpene saponins from callus tissue of Polygala amarella. J Nat Prod 62:923–926

    Article  PubMed  Google Scholar 

  13. Lin KT, Lien JC, Chung CH, Kuo SC, Huang TF (2010) A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis. Eur J Pharmacol 630:53–60

    Article  CAS  PubMed  Google Scholar 

  14. Drabkin DL, Austin JH (1935) Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J Biol Chem 112:51–65

    CAS  Google Scholar 

  15. Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA (2003) Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol 162:933–943

    Article  CAS  PubMed  Google Scholar 

  16. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273:30336–30343

    Article  CAS  PubMed  Google Scholar 

  17. Ek ETH, Dass CR, Choong PFM (2006) PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 12:497–502

    Article  CAS  PubMed  Google Scholar 

  18. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RN, Sasisekharan R, Fan TP (2004) Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110:1219–1225

    Article  CAS  PubMed  Google Scholar 

  19. Leung KW, Cheung LWT, Pon YL, Wong RNS, Mak NK, Fan TP, Au SCL, Tombran-Tink J, Wong AST (2007) Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol 152:207–215

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Koshiro Company Ltd. for kindly providing the Polygala senega. The authors are grateful to the Hoh-ansha Foundation and the Uehara Memorial Foundation for the financial support. This study was also financially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Motomasa Kobayashi.

Additional information

M. Arai and A. Hayashi contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arai, M., Hayashi, A., Sobou, M. et al. Anti-angiogenic effect of triterpenoidal saponins from Polygala senega . J Nat Med 65, 149–156 (2011). https://doi.org/10.1007/s11418-010-0477-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-010-0477-7

Keywords

Navigation